Biltmore Family Office, LLC Abbott Laboratories Transaction History

Biltmore Family Office, LLC

$566 Million
Q3 2024

A detailed history of Biltmore Family Office, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Biltmore Family Office, LLC holds 29,431 shares of ABT stock, worth $3.8 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

29,431

Previous 29,666 0.79%

Holding current value

$3.8 Million

Previous $3.08 Million 8.86%

% of portfolio

0.59%

Previous 0.58%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $23,516 - $27,760	-235 Reduced 0.79%	29,431 $3.36 Million
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $36,061 - $40,253	358 Added 1.22%	29,666 $3.08 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $34,608 - $38,223	316 Added 1.09%	29,308 $3.33 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $476,790 - $531,243	-4,731 Reduced 14.03%	28,992 $3.16 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $285,252 - $335,759	-2,945 Reduced 8.03%	33,723 $3.41 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $421,020 - $493,922	4,429 Added 13.74%	36,668 $4.03 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $5,128 - $5,937	53 Added 0.16%	32,239 $3.12 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $3,062 - $3,701	30 Added 0.09%	32,186 $3.5 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $878,980 - $1.07 Million	-7,709 Reduced 19.34%	32,156 $3.81 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $20,217 - $24,755	-175 Reduced 0.44%	39,865 $5.61 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $852,201 - $942,783	7,305 Added 22.32%	40,040 $4.73 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $29,938 - $35,241	283 Added 0.87%	32,735 $3.8 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.0%	32,452 $3.89 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $485,625 - $529,192	-4,625 Reduced 12.47%	32,451 $3.55 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $810,372 - $984,137	-8,843 Reduced 19.26%	37,076 $4.04 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $326,035 - $417,284	-4,258 Reduced 8.49%	45,919 $4.2 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $23,997 - $35,090	382 Added 0.77%	50,177 $3.96 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $25,594 - $28,492	-326 Reduced 0.65%	49,795 $4.33 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $13,244 - $16,012	-200 Reduced 0.4%	50,121 $4.01 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $27,076 - $30,673	413 Added 0.83%	50,321 $3.64 Million
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $108,922 - $120,217	-1,892 Reduced 3.65%	49,908 $3.04 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $2.78 Million - $2.98 Million	51,800	51,800 $2.96 Million

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Abbott Laboratories Transaction History